NCT05674916

Brief Summary

The POCUS PATHWAY-trial is a multi-center, randomized, investigator-initiated, open labelled, pragmatic, controlled trial of a point-of-care ultrasound-driven diagnostic pathway vs standard diagnostic pathway in dyspneic emergency department patients. The primary outcome will be 24-hour hospital stay and 642 patients will be included. Key secondary outcomes include overall hospital length of stay, image resources, and 72-hour revisits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
674

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 9, 2023

Completed
16 days until next milestone

Study Start

First participant enrolled

January 25, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 24, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2024

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

1.6 years

First QC Date

December 16, 2022

Last Update Submit

September 27, 2024

Conditions

Keywords

Point-of-care UltrasoundEmergency MedicineDiagnostic pathways

Outcome Measures

Primary Outcomes (1)

  • 24-hour hospital stay

    Proportion of patients with a hospital lenght-of-stay of less than 24 hours.

    From date of hospital admission until the date of first documented hospital discharge, assessed up to 24 hours.

Secondary Outcomes (3)

  • Hospital length-of-stay

    From date of hospital admission until the date of first documented hospital discharge, assessed up to 3 months.

  • Image resources

    From date of hospital admission until the date of first documented hospital discharge, assessed up to 3 months.

  • Number of participants with the composite outcome of 72-hour revisits and overall mortality

    From date of hospital admission until 72 hours after the date of first documented hospital discharge, assessed up to 3 months.

Study Arms (2)

Point-of-care ultrasound-driven diagnostic pathway

EXPERIMENTAL

The intervention is focused lung and cardiac ultrasound performed as an extension to physical examinations plus diagnostic decision recommendations based on those test results (a point-of-care ultrasound-driven diagnostic pathway). Final decision on next-line imaging and further diagnostic testing should incorporate history and other physical examinations and will remain upon the treating physicians' discretion.

Diagnostic Test: Point-of-care ultrasound-driven diagnostic pathway

Standard diagnostic pathway

NO INTERVENTION

Standard diagnostic pathway will include, but not be limited to, blood samples, blood gases, electrocardiogram, and chest x-ray. Focused lung and cardiac ultrasound cannot be performed while the patients stay in the emergency department.

Interventions

Focused lung ultrasound will include 8 zones (anterior and lateral) and evaluate pneumothorax, interstitial syndrome, lung consolidation, and pleural effusion. Focused cardiac ultrasound will include four views (subxiphoid four-chamber view, parasternal long-axis view, parasternal short-axis view, and apical four-chamber view) and evaluate pericardial fluid, right ventricle dilation, and left ventricular systolic contractility.

Point-of-care ultrasound-driven diagnostic pathway

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Emergency department contact
  • Age ≥ 18 years
  • Chief complaint is Dyspnea
  • Including physician present

You may not qualify if:

  • Fulfilling of criteria for coded rapid-response teams (i.e., trauma, surgical or medical emergencies).
  • Prior focused lung or focused cardiac ultrasound in the current emergency department stay
  • Prior enrollment in the trial
  • Unable to consent
  • Non Danish-speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Herlev Hospital

Herlev, Capital Denmark Region, 2730, Denmark

Location

Aarhus University Hospital

Aarhus, Central Jutland, 8200, Denmark

Location

Gødstrup Regional Hospital

Gødstrup, Central Jutland, 7400, Denmark

Location

Horsens Regional Hospital

Horsens, Central Jutland, 8700, Denmark

Location

Viborg Regional Hospital

Viborg, Central Jutland, 8800, Denmark

Location

University Hospital of Southern Denmark, Esbjerg

Esbjerg, Region Syddanmark, 6700, Denmark

Location

Odense University Hospital

Odense, Region Syddanmark, 5000, Denmark

Location

Zealand University Hospital, Køge

Køge, Zealand Denmark Region, 4600, Denmark

Location

Slagelse Hospital

Slagelse, Zealand Denmark Region, 4200, Denmark

Location

Related Links

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Stig H Ovesen

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Principal Investigator

Study Record Dates

First Submitted

December 16, 2022

First Posted

January 9, 2023

Study Start

January 25, 2023

Primary Completion

August 24, 2024

Study Completion

September 25, 2024

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Six months after the publication of the last results, all de-identified individual patient data will be made available for data sharing.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
There will be no predetermined end date for the data sharing.
Access Criteria
Data will be available for any research purpose to all interested parties who have approval from an independent review committee and who have a methodological sound proposal as determined by the steering committee of the current trial. Only the methodological qualities and not the purpose or objective of the proposal will be considered. Interested parties will be able to request the data by contacting the principal investigator.

Locations